Phastar and Medrio have been partnering together on trials for the past 3 years, culminating in a unique way to visualize clinical trial data. Through the use of Medrio’s API, Phastar has built a data visualization tool that reduces risk and allows for complete study oversight. In this podcast we’ll discuss the need for data visualization in clinical trials, how Phastar has continued their trials during a global pandemic, and what their thoughts are on the future of how we collect and view data.
It’s no secret that the United States has documented disparities in morbidity and mortality rates among racial/ethnic minority groups and those of lower socioeconomic...
Due to COVID-19 the clinical trial industry has been adopting advanced clinical trial technology at warp speed, but what does this mean for the...
Approximately 39.5% of all men and women will be diagnosed with cancer at some point during their lifetimes, and yet only 8% of oncology...